Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > I still expect 50 to 100 percent increase in stock rice
View:
Post by frankman on Dec 19, 2024 3:33pm

I still expect 50 to 100 percent increase in stock rice

Into March 2025  as I said before. a good doublte to start. End of message.
Comment by Hideaway on Dec 20, 2024 10:30am
Frankman,I hope you are proven correct but I'm hesitant to increase my position.Passins last newsletter gave a great picture as to the potential for Biov but getting pharma onboard will be no easy task for junior biotech trading in the 5 and 6 cent range.They can't conduct further clinical trials without money and backing. The SP did not move much as a result of the impressive newsletter.a ...more  
Comment by frankman on Dec 20, 2024 11:27am
Hideaway absolutely agree. In the early days though they did have temporary corroboration with Merck. They only had two vaccines then. With DPX the products are almost endless. And they do have interested parties. As far as promotion goes he has been the same way since inception, as all of 2024 with about thirty or so press releases. He once told me he wanted to increase exposure to the Canadian ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities